Literature DB >> 522426

Immunoreactive serum trypsin in diseases of the pancreas.

H C Heinrich, E E Gabbe, F Icagić.   

Abstract

Immunoreactive serum trypsin was measured with a double antibody radioimmunoassay in normal subjects and patients with various diseases of the pancreas. The normal range is 115-350 ng/ml with a geometric mean of 212 ng/ml. No trypsin was found in serum after total duodenopancreatectomy, in about 75% of patients with cystic fibrosis and in a few patients with pancreas carcinoma or chronic pancreatitis. Reduced serum trypsin levels between 10 and 100 ng/ml were measured in the remaining 25% of cystic fibrosis and in one third of the patients with chronic pancreatitis. Serum trypsin was increased to 700-17,000 ng/ml in all patients with acute pancreatitis or during the acute phase of chronic pancreatitis. Absent or reduced serum trypsin is a reliable indicator of total or partial exocrine pancreatic insufficiency whereas considerably increased serum trypsin concentration do indicate acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 522426     DOI: 10.1007/BF01489252

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  7 in total

1.  Isolation of human trypsin by affinity chromatography.

Authors:  R S Temler; J H Kägi
Journal:  Enzyme       Date:  1977

2.  Radioimmunoassay for pancreatic carboxypeptidase B in human serum.

Authors:  M C Geokas; F Wollesen; H Rinderknecht
Journal:  J Lab Clin Med       Date:  1974-10

3.  [Radio-immunologic measurement of trypsin in chronic pancreatitis. Preliminary results].

Authors:  C Gobelet; J Bambule; J P Felber; P Magnenat; R Séchaud
Journal:  Schweiz Med Wochenschr       Date:  1978-12-02

4.  Serum trypsin concentrations in diabetes mellitus.

Authors:  P Dandona; E Elias; A G Beckett
Journal:  Br Med J       Date:  1978-10-21

5.  Radioimmunoassay of human plasma trypsin.

Authors:  R S Temler; J P Felber
Journal:  Biochim Biophys Acta       Date:  1976-10-11

6.  Enteropancreatic circulation of trypsin in man.

Authors:  H C Heinrich; E E Gabbe; J Brüggemann; F Icagić; M Classen
Journal:  Klin Wochenschr       Date:  1979-12-03

7.  Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin.

Authors:  E Elias; M Redshaw; T Wood
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321

  7 in total
  8 in total

Review 1.  Exocrine pancreatic function tests.

Authors:  P G Lankisch
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

Review 2.  Function tests in the diagnosis of chronic pancreatitis. Critical evaluation.

Authors:  P G Lankisch
Journal:  Int J Pancreatol       Date:  1993-08

3.  Enteropancreatic circulation of trypsin in man.

Authors:  H C Heinrich; E E Gabbe; J Brüggemann; F Icagić; M Classen
Journal:  Klin Wochenschr       Date:  1979-12-03

4.  Serum elastase 1 in chronic pancreatic disease.

Authors:  G Del Favero; C Fabris; M Plebani; A Panucci; A Piccoli; L Perobelli; A Burlina; R Naccarato
Journal:  Klin Wochenschr       Date:  1985-07-01

5.  Variations with age of immunoreactive serum trypsin: higher reference ranges in "healthy" elderly people.

Authors:  R W Ammann; P Pei; N Satz; W Woodtli
Journal:  Klin Wochenschr       Date:  1982-03-01

6.  Characterization of temporospatial distribution of renal tubular casts by nephron tracking after ischemia-reperfusion injury.

Authors:  Naomi S Shin; Arnaud Marlier; Leyuan Xu; TuKiet Lam; Lloyd G Cantley; Jian-Kan Guo
Journal:  Am J Physiol Renal Physiol       Date:  2022-01-31

7.  Detection of Sub-Nanomolar Concentration of Trypsin by Thickness-Shear Mode Acoustic Biosensor and Spectrophotometry.

Authors:  Ivan Piovarci; Sopio Melikishvili; Marek Tatarko; Tibor Hianik; Michael Thompson
Journal:  Biosensors (Basel)       Date:  2021-04-11

8.  Remote biosensor for the determination of trypsin by using nanoporous anodic alumina as a three-dimensional nanostructured material.

Authors:  Mahmoud Amouzadeh Tabrizi; Josep Ferré-Borrull; Lluis F Marsal
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.